---
title: "Shanghai RAAS has repurchased a total of 0.70% of its shares, costing approximately 320 million yuan"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/239095156.md"
description: "According to the Zhitong Finance APP, Shanghai RAAS announced that as of May 7, 2025, the company has cumulatively repurchased 46.7298 million shares through a dedicated securities account for share repurchase via centralized bidding, accounting for 0.70% of the company's total share capital. The highest transaction price was 7.09 yuan/share, the lowest transaction price was 6.62 yuan/share, and the total transaction amount was 320 million yuan"
datetime: "2025-05-07T10:19:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239095156.md)
  - [en](https://longbridge.com/en/news/239095156.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239095156.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/239095156.md) | [English](https://longbridge.com/en/news/239095156.md)


# Shanghai RAAS has repurchased a total of 0.70% of its shares, costing approximately 320 million yuan

According to the Zhitong Finance APP, Shanghai RAAS (002252.SZ) announced that as of May 7, 2025, the company has cumulatively repurchased 46.7298 million shares through a dedicated securities account for share repurchase via centralized bidding, accounting for 0.70% of the company's total share capital, with a highest transaction price of 7.09 yuan/share, a lowest transaction price of 6.62 yuan/share, and a total transaction amount of 320 million yuan

### 相關股票

- [Shanghai RAAS (002252.CN)](https://longbridge.com/zh-HK/quote/002252.CN.md)

## 相關資訊與研究

- [Jiangsu Alcha Aluminium Unit Wins Bid for Shanghai RAAS Blood Products' Project](https://longbridge.com/zh-HK/news/280475232.md)
- [China Youran Dairy Further Delays Circular on Share Subscription and Whitewash Waiver](https://longbridge.com/zh-HK/news/281536370.md)
- [Ericsson extends partnership with Virgin Media O2](https://longbridge.com/zh-HK/news/281146790.md)
- [Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst⢠(bumetanide nasal spray)](https://longbridge.com/zh-HK/news/281570860.md)
- [BYD launches 2026 Seal 06 GT and wagon models equipped with ultra-fast charging tech](https://longbridge.com/zh-HK/news/281493817.md)